27th August 2015
For latest updates
Coming next week
Reports from European Society of Cardiology Congress 2015
29th August - 2nd September 2015
London, United Kingdom
will be publishing regular reports from the congress focussing on news about the science and clinical use of PCSK9 inhibitors.
Expert lectures on-line
International panel addresses key questions
How is imaging likely to change our understanding and treatment of atherosclerosis?
What is the clinical impact of very low LDL-C?
What’s new in clinical trials of PCSK9 inhibitors?
What are the unanswered questions in PCSK9 inhibition?
How do genetic and phenotypic variations in FH affect risk?
What are the therapeutic options in patients who cannot tolerate statins?
In the news
Is there a role for PCSK9 inhibition in sepsis treatment?
A new review of recent studies suggests that the potential clinical value of PCSK9 inhibition in people with sepsis should be investigated.
Read the full report »
Antisense PCSK9 inhibitor study halted
Study of the first antisense inhibitor of PCSK9 has been terminated due to adverse events.
Read the report »
Understanding PCSK9 inhibition
For healthcare professionals
Prepared by independent experts from
PCSK9 Education and Research Forum
to registered members of the Forum.
Register and read online »
Download now »
Like us on Facebook
For the latest updates on conferences, PCSK9 news and video reports.
Follow us on Twitter
For updates on hot topics,
PCSK9 news and conference reports.
For the latest videos, interviews and webcasts from leading experts.
Copyright PCSK9 Forum 2015.
Please click here to unsubscribe from future mailings.